TILT Trademark

Trademark Overview


On Thursday, March 16, 2017, a trademark application was filed for TILT with the United States Patent and Trademark Office. The USPTO has given the TILT trademark a serial number of 79211600. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Friday, October 4, 2024. This trademark is owned by TILT Biotherapeutics Oy. The TILT trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical services in the field of cancer; medical treatment services, namely, medical treatment of cancerous diseases; medical analysis services for the diagnosis of cancer; providing cancer screening services; medical laboratory services for the analysis of samples taken from patients for the purpose of diagnosing cancer [ ; consultancy relating to medical services in the field of cancerous diseases ]

Scientific research and development for medical purposes; medical and biotechnological research; scientific research for medical purposes in the area of cancerous diseases; providing information and data relating to medical research and development in the field of cancer research and disease classification; pharmaceutical products development [ ; biochemical research and development; medical laboratory services, namely, medical testing, medical laboratory analysis in the field of biotechnology, and medical research; consultancy relating to scientific research and development in the field of biotechnology and medical research ]
tilt

General Information


Serial Number79211600
Word MarkTILT
Filing DateThursday, March 16, 2017
Status706 - SECTION 71 ACCEPTED
Status DateFriday, October 4, 2024
Registration Number5352787
Registration DateTuesday, December 12, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 26, 2017

Trademark Statements


Goods and ServicesMedical services in the field of cancer; medical treatment services, namely, medical treatment of cancerous diseases; medical analysis services for the diagnosis of cancer; providing cancer screening services; medical laboratory services for the analysis of samples taken from patients for the purpose of diagnosing cancer [ ; consultancy relating to medical services in the field of cancerous diseases ]
Goods and ServicesScientific research and development for medical purposes; medical and biotechnological research; scientific research for medical purposes in the area of cancerous diseases; providing information and data relating to medical research and development in the field of cancer research and disease classification; pharmaceutical products development [ ; biochemical research and development; medical laboratory services, namely, medical testing, medical laboratory analysis in the field of biotechnology, and medical research; consultancy relating to scientific research and development in the field of biotechnology and medical research ]

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, July 8, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, July 8, 2017
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTILT Biotherapeutics Oy
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressHelsinki 00290
FI

Party NameTILT Biotherapeutics Oy
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressFI

Party NameTILT Biotherapeutics Oy
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressFI

Trademark Events


Event DateEvent Description
Thursday, July 6, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Saturday, July 8, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 8, 2017ASSIGNED TO EXAMINER
Wednesday, July 12, 2017APPLICATION FILING RECEIPT MAILED
Wednesday, July 12, 2017NON-FINAL ACTION WRITTEN
Thursday, July 13, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, July 20, 2017REFUSAL PROCESSED BY MPU
Thursday, July 20, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, August 4, 2017REFUSAL PROCESSED BY IB
Tuesday, August 8, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 8, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 8, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 11, 2017EXAMINERS AMENDMENT -WRITTEN
Friday, August 11, 2017EXAMINERS AMENDMENT E-MAILED
Friday, August 11, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, August 11, 2017EXAMINER'S AMENDMENT ENTERED
Friday, August 11, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 6, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 26, 2017PUBLISHED FOR OPPOSITION
Tuesday, September 26, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 12, 2017REGISTERED-PRINCIPAL REGISTER
Monday, March 12, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, March 26, 2018FINAL DISPOSITION PROCESSED
Monday, March 26, 2018FINAL DISPOSITION NOTICE SENT TO IB
Saturday, May 12, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, August 30, 2018NEW REPRESENTATIVE AT IB RECEIVED
Monday, December 12, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, December 7, 2023TEAS SECTION 71 RECEIVED
Monday, September 9, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, September 17, 2024POST REGISTRATION ACTION MAILED - SEC.71
Thursday, September 19, 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Friday, October 4, 2024REGISTERED-SEC.71 ACCEPTED
Friday, October 4, 2024NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Wednesday, June 4, 2025PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Monday, October 27, 2025INVALIDATION PROCESSED
Monday, October 27, 2025PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Saturday, November 15, 2025PARTIAL INVALIDATION PROCESSED BY THE IB